The plaintiffs alleged that the insurer misled members with lists of in-network providers that turned out to be unreachable, out-of-network or non-existent.

AstraZeneca has now become the second big drug maker to agree to offer Medicaid its best prices, through a "most-favored-nation" agreement with the administration of President Donald Trump.

Vanguard officials said that two key levers would lead to greater improvement: continued expansion of DC plan access and two additional years of work.